Canadian Pacific Kansas City Limited Common Shares vs Cytokinetics Inc — how do they compare? Canadian Pacific Kansas City Limited Common Shares trades at $84.16 (market cap $73.98B), while Cytokinetics Inc trades at $62.75 (market cap $8.62B). The key difference: Canadian Pacific Kansas City Limited Common Shares is far larger — about 8.6× Cytokinetics Inc's market cap, and Canadian Pacific Kansas City Limited Common Shares pays a 0.9% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.
| CP | CYTK | |
|---|---|---|
Market Cap | $73.98B | $8.62B |
Volume | 1,669,828 | 2,594,626 |
Sector | Industrials | Health |
52-Week High | $96.69 | $87.26 |
52-Week Low | $68.88 | $54.76 |
Enterprise Value | $91.36B | $8.72B |
Dividend Yield | 0.9% | — |
Typical Hold Time | — | 19 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Cytokinetics (CYTK) trades at $62.48, up 2.23% today, but faces bearish technical signals with 18 sell indicators versus 4 buy signals. The company shows strong revenue growth potential with recent positive Phase 3 trial results for aficamten in non-obstructive HCM, though it operates at significant losses with a -1,321% net income margin. Cash flow remains heavily dependent on financing activities, with operating cash flow negative at -$555 million in 2026.
Wall Street maintains strong bullish sentiment with 97% buy ratings and a $112.60 consensus price target, representing 80% upside potential. Key risks include continued cash burn, competitive pressure from Bristol Myers Squibb's Camzyos, and the need for successful commercialization of pipeline drugs. The stock's valuation appears stretched at 114x sales given current financial performance.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Canadian Pacific Kansas City operates a freight railway connecting Canada, the United States, and Mexico. The company was formed through the combination of Canadian Pacific and Kansas City Southern.
Read more on CP →Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →